Artificial Intelligence (AI) has left behind its sci-fi roots have become immersed in production, in the distribution chain, in retail and in business, yet a space in which it is really intended to realize a tangible impact on life is already in place in health care. or develop areas, improve patient care and management, and transform patient diagnosis and care
The health sector may be late when it comes to the application and implementation of artificial intelligence, but it is expected to change in the next three or five years according to Frost & amp; Sullivan. Health institutions around the world are studying the potential of AI and investing in solutions that could shift their care parameters.
In the United Kingdom, the NHS has already engineered AI innovation with solutions such as the HeartFlow FFRCT analysis using artificial intelligence to diagnose coronary heart disease and the Babylon app that uses machine learning and artificial intelligence to help clinicians diagnose symptoms more accurately. The National Health Institute has also started the program DigitalHealth .London – an accelerator program that was designed to accelerate the adoption of technology using the latest invention and the invention of SMEs.
The goal of the accelerator is to identify companies that have developed tools that will reduce the increasing pressure on services and allow patients to take an active role in their health care. It addresses the challenges currently faced by the national health service by engaging with doctors and health experts, creating collaborative opportunities to assess health and care problems and develop functional solutions.
One of the most recent additions to the acceleration program is Trustedoctor a global digital healthcare platform that makes it easier for cancer patients to access specialist care. DigitalHealth.London will support Trustedoctor in implementing a solution that could help alleviate the complexities surrounding ongoing cancer care and support.
"Unfortunately, in the UK we still have lower cancer survival rates than most Western Europe," says Professor Karol Sikora, a professor of oncology and a medical dean at the University of Buckingham. "Trustedoctor's technology could help improve connectivity between patients, doctors and the NHS Trust, accelerating the diagnosis, and could also ensure that the right skills can be brought to the patient more quickly and effectively, even to those who live in a certain distance from an oncology center. "
Simplifying Oncology
One of the challenges for cancer care is that patients maintain regular follow-up appointments or provide specialists able to give them a second opinion. It is a complex labyrinth that adds more weight to what cancer patients already carry as they travel from an appointment to home treatment. Trustedoctor minimizes this pressure by connecting patients and specialists through technology.
CEO and co-founder of Trustedoctor & nbsp; Greg Jarzabek says, & nbsp;
Our solution provides physicians with virtual links to manage patient referrals, groomed transfers and structured medical records, consult and collaborate. We know that in many cases we can have doctors who respond to patient requests within 12-24 hours with a consultation that occurs on the same day. We have already demonstrated the concept in the private sector and now we are trying to bring the benefits to the NHS through this acceleration program.
The role of the AI-inspired startup is to reduce delivery times for regular follow-ups and second opinions within the national health service, shifting the largely phone-based service to a platform digital. Patients use videoconferencing to talk to specialists about their home, ensuring they receive continued care after being released from the hospital. Thanks to technology, the patient does not have to sit in a queue or drive or wait hours. They can use the system to notify their doctor about concerns after surgery or treatment and receive information within a few hours.
The Trustedoctor Patient Link platform provides patients with a secure space to upload their records, including all their scans, images and reports. highly protected profile that can then share digitally with a relevant doctor. The platform is designed to give patients full control over who they invite to view their records, so even their local GP can also get information about their status and their diagnosis. It has the potential to improve the tightness and uniformity of registrations in the entire patient portfolio, reducing risks and improving patient care.
Trustedoctor could be a great resource for the national health service facilitating virtual consultations, allowing patients to enjoy the advantage and convenience of their own home and the release of valuable clinical space in hospitals for those patients requiring an appointment on the spot [19659015] adds Paul Grundy, neurosurgeon consultant, Southampton Hospital, president of the clinical reference group of NHS England for cancer and CNS secretary of the British Neuro-Oncology Society.
By using the accelerator, Trustedoctor will connect with the NHS stakeholders, industry investors, patients and other healthtech innovators so that it can continually adapt its offer to meet the real needs of the NHS. The artificial intelligence solution opens up a world of oncology specialists to people who have been diagnosed with cancer, who are treated and need medical assistance they can trust while mitigating some of the biggest challenges of the system national health
">
Artificial Intelligence (AI) has long left its science fiction roots and has immersed itself in production, in the supply chain, retail and commercial activities, however, a space where it is intended to concretely realize a life-saving impact concerns health care.There are already applications that provide essential assistance to people in underdeveloped areas or developing, improving patient data management and managing and transforming diagnosis and patient care.
According to research conducted by Frost & Sullivan, AI in the healthcare market will reach $ 6.16 billion by 2022. It is also set to save the health sector $ 150 billion by 2025 thanks to its ability to minimize complexity, reduce hi, improve accuracy and increase profitability. Its potential is high, but its spread has been slow.
Inside the Intelligent Mind
The health sector may be late when it comes to the application and implementation of IA, but this should change in the next three to five years according to Frost & Sullivan . Health institutions around the world are studying the potential of artificial intelligence and investing in solutions that could shift their care parameters.
In the United Kingdom, the NHS has already engineered AI innovation with solutions like the HeartFlow FFRCT analysis that uses artificial intelligence to diagnose coronary heart disease and 39; Babylon app that uses machine learning and artificial intelligence to help doctors diagnose symptoms more accurately. The national health institute has also launched DigitalHealth.London, an accelerator program designed to accelerate the adoption of technology using the latest innovations in SME start-up and invention.
The goal of the accelerator is to identify companies that have developed tools that reduce the increasing pressure on services and allow patients to take an active role in their health care. It addresses the challenges currently faced by the national health service by engaging with doctors and health experts, creating collaborative opportunities to assess health and care problems and develop functional solutions.
One of the most recent additions to the acceleration program is Trustedoctor, a global digital healthcare platform that makes it easier for cancer patients to access specialist care. DigitalHealth.London will support Trustedoctor in implementing a solution that could help alleviate the complexities surrounding ongoing cancer care and support.
"Unfortunately, in the UK we still have lower cancer survival rates than most Western Europe," says Professor Karol Sikora, a professor of oncology and a medical dean at the University of Buckingham. "Trustedoctor's technology could help improve connectivity between patients, doctors and the NHS Trust, accelerating the diagnosis, and could also ensure that the right skills can be brought to the patient more quickly and effectively, even to those who live in a certain distance from an oncology center. "
Simplifying Oncology
One of the challenges for cancer care is that patients maintain regular follow-up appointments or provide specialists able to give them a second opinion. It is a complex labyrinth that adds more weight to what cancer patients already carry as they travel from an appointment to home treatment. Trustedoctor minimizes this pressure by connecting patients and specialists through technology.
Trustedoctor CEO and co-founder Greg Jarzabek says,
Our solution provides physicians with virtual links to manage patient referrals, transfer curated and structured medical records, consult and collaborate. We know that in many cases we can have doctors who respond to patient requests within 12-24 hours with a consultation that occurs on the same day. We have already demonstrated the concept in the private sector and now we are trying to bring the benefits to the NHS through this acceleration program.
The role of the AI-inspired startup is to reduce delivery times for regular follow-ups and second opinions within the national health service, shifting the largely phone-based service to a platform digital. Patients use videoconferencing to talk to specialists about their home, ensuring they receive continued care after being released from the hospital. Thanks to technology, the patient does not have to sit in a queue or drive or wait hours. They can use the system to notify their doctor about concerns after surgery or treatment and receive information within a few hours.
The Trustedoctor Patient Link platform provides patients with a secure space to upload their records, including all their scans, images and reports. highly protected profile that can then share digitally with a relevant doctor. The platform is designed to give patients full control over who they invite to view their records, so even their local GP can also get information about their status and their diagnosis. It has the potential to improve the tightness and uniformity of registrations in the entire patient portfolio, reducing risks and improving patient care.
Trustedoctor could be a great resource for the national health service facilitating virtual consultations, allowing patients to enjoy the advantage and convenience of their own home and the release of valuable clinical space in hospitals for those patients requiring an appointment on the spot [19659015] adds Paul Grundy, neurosurgeon consultant, Southampton Hospital, president of the clinical reference group of NHS England for cancer and CNS secretary of the British Neuro-Oncology Society.
By using the accelerator, Trustedoctor will connect with the NHS stakeholders, industry investors, patients and other healthtech innovators so that it can continually adapt its offer to meet the real needs of the NHS. The artificial intelligence solution opens up a world of oncology specialists to people who have been diagnosed with cancer, who are treated and need medical assistance they can trust while mitigating some of the biggest challenges of the system national health